Developing extracellular vesicle therapy for the treatment of severe dermatological disorders including epidermolysis bullosa.
Privately Funded Company
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):